NEXUS
Commercial- Indications
- Aortic arch aneurysm, Aortic arch dissection
Company intelligence / Profile preview
Endospan
Herzliya, Israelendospan.com ↗
- Ownership
- Private
- Employees
- ~54
- Development stage
- Commercial
01
Overview
Endospan’s NEXUS system is the first and only approved branched endovascular stent graft for treating complex aortic arch disease, including aneurysms and dissections. The TRIOMPHE pivotal IDE trial has shown promising early results, with 30-day data demonstrating significant reduction in major adverse events compared to reference performance goals. The device is already approved and commercialized in Europe; U.S. approval is anticipated following completion of ongoing pivotal studies.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceStent graft systemBiologic (as a device incorporating biologically compatible materials)
- Industry
- Implantable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Artivion (strategic/financial partnership for U.S. FDA approval path)
Beyond the preview
Go deeper on Endospan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Endospan.